Reversible RNA Acylating Reagents with Nitro Reduction Strategy
Preprint
Abstract
We developed a series of nitro reduction-reversible acylating reagents. Following optimization of the acylation conditions, these reagents were tested for deacylation with sodium dithionite in vitro . We applied this reversible acylation to modulate RNAzyme-mediated pre-tRNA maturation, demonstrating its ability to regulate RNA-RNA interactions. Furthermore, the in vitro reversible acylation of EGFP mRNA indicated effective control of its translational activity. To explore cellular applications, we validated NQO1-mediated deacylation in vitro and then induced hypoxia in HepG2 cells using cobalt chloride, thereby reactivating the function of acylated EGFP mRNA via endogenous NQO1. Overall, this study highlights the potential for developing nitro reduction-reversible acylation as a new strategy for RNA functional control and RNA-based drug modification.Keywords
This publication has 32 references indexed in Scilit:
- Enhanced control of RNA modification and CRISPR-Cas activity through redox-triggered disulfide cleavageBioorganic & Medicinal Chemistry, 2024
- Nitroreductase-induced bioorthogonal ligation for prodrug activation: A traceless strategy for cancer-specific imaging and therapyBioorganic Chemistry, 2022
- Hydrogen Peroxide‐triggered Chemical Strategy for Controlling CRISPR systemsChemistry – An Asian Journal, 2022
- Microwave‐assisted reduction of aromatic nitro compounds with novel oxo‐rhenium complexesApplied Organometallic Chemistry, 2021
- siRNA: Mechanism of action, challenges, and therapeutic approachesEuropean Journal of Pharmacology, 2021
- Prodrugs for Nitroreductase Based Cancer Therapy‐5: Development of Trinitroaniline Prodrugs/Ssap‐NtrB Combinations for Liver Cancer Using Intracellular and Extracellular ConditionsChemistrySelect, 2021
- RNA Cloaking by Reversible AcylationAngewandte Chemie International Edition, 2018
- Glutathione: Overview of its protective roles, measurement, and biosynthesisMolecular Aspects of Medicine, 2009
- Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive bindingBioorganic & Medicinal Chemistry, 2006
- Ribonuclease P: An Enzyme with a Catalytic RNA Subunit1989